522 related articles for article (PubMed ID: 25320371)
61. Advanced human T-cell leukemia virus type 1 carriers and early-stage indolent adult T-cell leukemia-lymphoma are indistinguishable based on CADM1 positivity in flow cytometry.
Kobayashi S; Watanabe E; Ishigaki T; Ohno N; Yuji K; Nakano K; Yamochi T; Watanabe N; Tojo A; Watanabe T; Uchimaru K
Cancer Sci; 2015 May; 106(5):598-603. PubMed ID: 25703103
[TBL] [Abstract][Full Text] [Related]
62. Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy.
Kannagi M; Hasegawa A; Nagano Y; Iino T; Okamura J; Suehiro Y
Cancer Sci; 2019 Mar; 110(3):849-857. PubMed ID: 30666755
[TBL] [Abstract][Full Text] [Related]
63. Autologous Tax-specific CTL therapy in a primary adult T cell leukemia/lymphoma cell-bearing NOD/Shi-scid, IL-2Rγnull mouse model.
Masaki A; Ishida T; Suzuki S; Ito A; Mori F; Sato F; Narita T; Yamada T; Ri M; Kusumoto S; Komatsu H; Tanaka Y; Niimi A; Inagaki H; Iida S; Ueda R
J Immunol; 2013 Jul; 191(1):135-44. PubMed ID: 23733874
[TBL] [Abstract][Full Text] [Related]
64. Human T-lymphotropic virus type 1 infection.
Tsukasaki K; Koeffler P; Tomonaga M
Baillieres Best Pract Res Clin Haematol; 2000 Jun; 13(2):231-43. PubMed ID: 10942623
[TBL] [Abstract][Full Text] [Related]
65. [Current status and future directions of ATL].
Ishida T
Rinsho Ketsueki; 2018; 59(10):2136-2145. PubMed ID: 30305519
[TBL] [Abstract][Full Text] [Related]
66. Development of Innate-Immune-Cell-Based Immunotherapy for Adult T-Cell Leukemia-Lymphoma.
Nakashima M; Tanaka Y; Okamura H; Kato T; Imaizumi Y; Nagai K; Miyazaki Y; Murota H
Cells; 2024 Jan; 13(2):. PubMed ID: 38247820
[TBL] [Abstract][Full Text] [Related]
67. Treatment of Adult T-Cell Leukemia/Lymphoma: Established Paradigms and Emerging Directions.
Stuver R; Horwitz SM; Epstein-Peterson ZD
Curr Treat Options Oncol; 2023 Aug; 24(8):948-964. PubMed ID: 37300656
[TBL] [Abstract][Full Text] [Related]
68. Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease.
Tsukasaki K; Tsushima H; Yamamura M; Hata T; Murata K; Maeda T; Atogami S; Sohda H; Momita S; Ideda S; Katamine S; Yamada Y; Kamihira S; Tomonaga M
Blood; 1997 Feb; 89(3):948-56. PubMed ID: 9028326
[TBL] [Abstract][Full Text] [Related]
69. Adult T-cell Leukemia/Lymphoma: A Problem Abroad and at Home.
Dittus C; Sloan JM
Hematol Oncol Clin North Am; 2017 Apr; 31(2):255-272. PubMed ID: 28340877
[TBL] [Abstract][Full Text] [Related]
70. [CCR4, HTLV-1 infection, and ATL oncogenesis].
Yoshie O
Uirusu; 2008 Dec; 58(2):125-40. PubMed ID: 19374191
[TBL] [Abstract][Full Text] [Related]
71. [Adult T cell leukemia-lymphoma with allo-HSCT after treatment for pulmonary involvement with Mogamulizumab].
Kawashima I; Sueki Y; Yamamoto T; Nozaki Y; Nakajima K; Mitsumori T; Kirito K
Rinsho Ketsueki; 2015 Feb; 56(2):210-5. PubMed ID: 25765802
[TBL] [Abstract][Full Text] [Related]
72. Adult T-cell leukemia.
Takatsuki K
Intern Med; 1995 Oct; 34(10):947-52. PubMed ID: 8563094
[TBL] [Abstract][Full Text] [Related]
73. [Development of future treatment for ATL].
Ishitsuka K
Rinsho Ketsueki; 2021; 62(7):766-773. PubMed ID: 34349061
[TBL] [Abstract][Full Text] [Related]
74. Treatment of adult T-cell leukemia.
Uozumi K
J Clin Exp Hematop; 2010; 50(1):9-25. PubMed ID: 20505272
[TBL] [Abstract][Full Text] [Related]
75. HTLV-I Tax related dysfunction of cell cycle regulators and oncogenesis of adult T cell leukemia.
Arima N; Tei C
Leuk Lymphoma; 2001 Jan; 40(3-4):267-78. PubMed ID: 11426548
[TBL] [Abstract][Full Text] [Related]
76. Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells.
Watanabe T
Blood; 2017 Mar; 129(9):1071-1081. PubMed ID: 28115366
[TBL] [Abstract][Full Text] [Related]
77. Microsatellite alterations are also present in the less aggressive types of adult T-cell leukemia-lymphoma.
Magalhães M; Oliveira PD; Bittencourt AL; Farre L
PLoS Negl Trop Dis; 2015 Jan; 9(1):e0003403. PubMed ID: 25590596
[TBL] [Abstract][Full Text] [Related]
78. Adult T-Cell Leukemia-Lymphoma.
Munakata W; Tobinai K
Cancer Treat Res; 2019; 176():145-161. PubMed ID: 30596217
[TBL] [Abstract][Full Text] [Related]
79. The state of the art in the pathogenesis of ATL and new potential targets associated with HTLV-1 and ATL.
Murata K; Yamada Y
Int Rev Immunol; 2007; 26(5-6):249-68. PubMed ID: 18027200
[TBL] [Abstract][Full Text] [Related]
80. Tumor immunity against adult T-cell leukemia.
Kannagi M; Harashima N; Kurihara K; Ohashi T; Utsunomiya A; Tanosaki R; Masuda M; Tomonaga M; Okamura J
Cancer Sci; 2005 May; 96(5):249-55. PubMed ID: 15904464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
